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Abstract
Background: Research suggests that diagnostic procedures for Autism Spectrum Disorder are not consistent across
practice and that diagnostic rates can be affected by contextual and social drivers. The purpose of this review was
to consider how the content of clinical practice guidelines shapes diagnoses of Autism Spectrum Disorder in the
UK; and investigate where, within those guidelines, social factors and influences are considered.
Methods: We electronically searched multiple databases (NICE Evidence Base; TRIP; Social Policy and Practice; US
National Guidelines Clearinghouse; HMIC; The Cochrane Library; Embase; Global health; Ovid; PsychARTICLES;
PsychINFO) and relevant web sources (government, professional and regional NHS websites) for clinical practice
guidelines. We extracted details of key diagnostic elements such as assessment process and diagnostic tools. A
qualitative narrative analysis was conducted to identify social factors and influences.
Results: Twenty-one documents were found and analysed. Guidelines varied in recommendations for use of diagnostic
tools and assessment procedures. Although multidisciplinary assessment was identified as the ‘ideal’ assessment, some
guidelines suggested in practice one experienced healthcare professional was sufficient. Social factors in operational,
interactional and contextual areas added complexity to guidelines but there were few concrete recommendations as to
how these factors should be operationalized for best diagnostic outcomes.
Conclusion: Although individual guidelines appeared to present a coherent and systematic assessment process, they
varied enough in their recommendations to make the choices available to healthcare professionals particularly complex
and confusing. We recommend a more explicit acknowledgement of social factors in clinical practice guidelines with
advice about how they should be managed and operationalised to enable more consistency of practice and
transparency for those coming for diagnosis.
Keywords: Autism spectrum disorder, Diagnosis, Clinical guideline, Narrative review, Social factors, Diagnostic
uncertainty, Clinical judgement
Background
The diagnosis of autism poses particular challenges for
healthcare professionals (HCPs) as, in common with other
neurodevelopmental disorders and most psychiatric disor-
ders, there are no biomarkers utilised in clinical practice
[1–3]. In addition, the condition is heterogeneous, with
wide ranging levels of severity and symptom expression
and characteristics common to autism may occur in
people with other conditions [4]. Those coming for
diagnosis may also have symptoms of other conditions
such as epilepsy, learning disability or sleep disorders, for
example, complicating diagnosis further, with some argu-
ing for a de-compartmentalisation of these conditions in
younger children [5]. The ‘gold standard’ of diagnosis is
considered to be consensus agreement within a
multi-agency team [6, 7]. However, negotiating consensus
between HCPs with different training, professional roles,
experience and knowledge can be challenging and time
consuming. Finally, a review of the accuracy, reliability,
validity and utility of reported diagnostic tools and assess-
ments found that many diagnostic instruments for autism
* Correspondence: Jennie.Hayes@exeter.ac.uk
University of Exeter Medical School, St Luke’s Campus, University of Exeter,
Exeter EX1 2LU, UK
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hayes et al. BMC Psychiatry  (2018) 18:222 
https://doi.org/10.1186/s12888-018-1800-1
lack a high-quality independent evidence base [6]. For ex-
ample, only three instruments - the Autism Diagnostic
Observation Schedule (ADOS), Autism Diagnostic Inter-
view Revised (ADI-R) and the Childhood Autism Rating
Scale (CARS) - had a strong supporting evidence base [6].
Given the potential challenges, clinical practice guide-
lines (CPGs) perform an important role in informing HCPs
of best practice. CPGs are ‘systematically developed state-
ments to assist practitioner and patient decisions about ap-
propriate health care for specific clinical circumstances’ [8].
National CPGs in the UK help to provide evidence-based
recommendations to support Autism Strategies and Action
Plans [9] and form the guidance framework for HCPs
undertaking assessment and diagnosis of autism in the UK.
In addition to CPGs produced by specialist, government
supported healthcare associations, for example, the
Scottish Intercollegiate Guidelines Network (SIGN) [10],
professional clinical bodies also publish discipline-specific
practice parameters or position papers, for example, the
Royal College of Psychiatrists (RCPsych) [11].
Social factors
Although CPGs aim to inform diagnostic practice, re-
search suggests that diagnostic and assessment procedures
vary in practice [9]. Diagnosis is dependent on observing
socially-based behaviours that are arguably not necessarily
characteristic of the person under assessment but arise
from two-way social relationships and social context.
Assessment mechanisms include drawing information
from a range of sources, including clinician observation,
reporting from family members and wider contexts such
as school or workplace. This means that assessments are
contextual and inter-relational and symptoms may change
according to context or interpersonal relationship, making
different assessment sources potentially contradictory.
Some studies show that social factors such as individ-
ual patient preference, availability of resources or local
organisational factors can shape diagnostic practice, in,
for example, heart disease [12]. Studies in autism have
also shown how diagnostic rates can be affected by
contextual and social drivers, such as diagnostic re-
sources [13] or diffusion of information about autism
through social networks [14]. Where there is diagnostic
uncertainty clinicians may ‘upgrade’ to a diagnosis of
autism if they believe it would be in the best interests of
the patient; if the diagnosis would trigger appropriate
services and funding; or counteract the limitations of
diagnostic tools, particularly in atypical presentations
[15, 16]. It seems, in practice, clinicians may adopt a
pragmatic, practical or functional approach.
Socio-economic and cultural factors
Research has shown that lower social economic status
(SES) is associated with increased parent-reported
prevalence [17], contrasting with the US where higher
SES and parental education is linked to increased likeli-
hood of diagnosis [14, 18]. Research also suggests that
people with autism from Black, Asian and Minority
Ethnic (BAME) communities are less likely to be
diagnosed with autism or access appropriate services
[19] despite research which shows that behaviours
associated with autism are likely to be consistent across
cultures and countries [20].
Prior to diagnosis, social factors can also determine
who comes forward for diagnosis and who is referred for
further assessment. Research examining a longitudinal
UK cohort study identified that with the severity of aut-
istic traits held constant, younger mothers and mothers
of first-born children were significantly less likely to have
children diagnosed with ASD [21]. In addition, boys
were more likely to receive a diagnosis than girls, and
maternal depression was linked with a lack of diagnosis
[21]. These findings suggest both cultural and economic
influences impact the diagnostic pathway.
Biomarkers in autism diagnosis
There is a great deal of research that explores the under-
lying neurobiological, genetic, chemical and cognitive
factors that may, in future, provide biomarkers which
could be utilised in autism diagnosis (see [22] for a review
of genetic, metabolic and brain focused biomarkers). For
example, a recent research study has identified a link be-
tween damage to proteins in blood plasma and autism
symptoms [23]; while another found shared brain activity
between boys diagnosed with ASD and those with
obsessive-compulsive disorder (OCD) which in turn dif-
fered from a non-diagnosed control group [24]. However,
it has been argued that the heterogeneous and interactive
nature of autism symptoms makes the identification of
clinically useful biomarker tests problematic [25]. Further-
more, findings from biomarker research have yet to be
integrated with clinical practice and none currently have
enough evidence to support routine clinical use [22]. For
the foreseeable future, therefore, these developments are
unlikely to change diagnostic practice [26].
Purpose of the review
Although a few studies have begun to explore health
professionals’ views of autism diagnosis [16, 27, 28], to
our knowledge there are few studies that examine how
clinical guidelines may inform assessment. One excep-
tion is a recent systematic review of English speaking
guidelines undertaken by Penner et al. [29] which
reported that guidelines varied considerably in quality,
content and recommendations but included guidelines
working across incomparable health systems in different
countries. We therefore carried out a focussed narrative
review of guidelines that impact on UK-based practice.
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Penner et al. suggest that in the face of disparate clinical
guidance clinicians should ‘be mindful of local resources
and wait times, eligibility requirements for ASD ser-
vices…and the wishes of families when deciding on how
best to assess for ASD’ [29]. Our narrative review re-
sponds to this call for a pragmatic approach by investi-
gating where, within guidelines, social factors and
influences such as those suggested are considered.
Method
Scoping search
A scoping search was undertaken to check there was no
similar review published. A search was made in the fol-
lowing databases; PsychARTICLES; Embase; Global
health; HMIC; Ovid (books; medline; journals); Psy-
chINFO; Social policy and practice. One relevant article
was retrieved [29], as discussed above.
Inclusion and exclusion criteria
Full inclusion and exclusion criteria are in Table 1.
Whilst we took a broad approach to CPGs, including,
for example, journal articles summarizing national CPGs
and the diagnostic process, as well as national CPGs, the
researchers acknowledge that each of these type of
guidelines have different purposes (see Table 2). How-
ever, we argue that each may have an impact on HCP’s
process of diagnosis to a greater or lesser extent and for
the purposes of this study all were included under the
term clinical practice guidelines.
Identification of CPGs
We did not set out to undertake a comprehensive sys-
tematic review, as it was not a requirement of our study
that we consider risk of bias either within or across
studies [30]. However, we took a PRISMA approach to
our search strategy, borrowing from systematic review
methodology in terms of screening titles and abstracts
and data extraction techniques [31]. A systematic search
was conducted in June 2017 using the following data-
bases: NICE Evidence Base; TRIP; Social Policy and
Practice; US National Guidelines Clearinghouse; HMIC;
The Cochrane Library. In addition, searches were made
of government related websites and relevant professional
bodies as well as NICE and SIGN. We used the follow-
ing search terms to search all databases and websites:
‘autism’, ‘diagnosis’, ‘guidance’, ‘statutory’, ‘clinical’, ‘practice’,
‘guideline’, ‘protocol’, ‘strategy’, ‘policy’, ‘bill’, ‘act’, and ‘par-
ameter’. A full search strategy is in Fig. 1.
Study selection
The first reviewer (JH) removed duplicates and screened
titles for relevance. Full text copies of the potentially rele-
vant documents were downloaded for screening. The first
reviewer screened full text documents and excluded those
not relevant. The remaining titles were independently
checked by the clinical specialist (TF) using pre-specified
inclusion/exclusion criteria (outlined in Table 1). Discrep-
ancies were resolved by discussion, with involvement of a
third reviewer (GR). Twenty-eight documents were
considered for analysis, with seven being withdrawn at full
analysis stage. See Fig. 2 for full details.
Guidelines from the International Classification of
Mental and Behavioural Disorders (Tenth edition)
(ICD-10) [32] and the Diagnostic and Statistical Manual
of Mental Disorders (Fifth edition) (DSM-5) [33] were
considered alongside UK relevant guidelines as they are
considered authoritative sources for the definition of
symptoms utilized in autism diagnosis, as well as other
neurological conditions.
Data extraction
A data extraction framework was created to draw key
characteristics from the guidelines (year, author, geo-
graphical remit, target audience, age range, range of
diagnoses covered, age at which symptoms are recog-
nised, diagnostic criteria referred to); as well as key ele-
ments in the diagnostic process (recommended tools,
role and composition of the multidisciplinary team
(MDT), who can diagnose, assessment targets and key
features of assessment). This framework was piloted with
Table 1 Inclusion and Exclusion Criteria
Inclusion Criteria
Documents with guidance-based status for HCPs working in secondary
care in the UK; or were published papers, aimed at HCPs, with the aim
of reviewing CPGs
Documents related to autism diagnosis and assessment for either
children, adults or both
Documents produced either by or through government or
professional clinical bodies or published in a journal aimed at HCPs
Documents related to diagnosis and assessment in UK (England,
Scotland, Wales and N Ireland)
Documents dated from 2009 (reflecting publication of the first UK
specific Autism Act) or were the most recent CPG published by a key
professional body
Exclusion Criteria
Documents related solely to referral, treatment, prognosis or support
services
Reviews of diagnostic criteria and other academic papers
Guidelines related to primary care as we were interested in diagnosis
rather than referral
Narrative reviews, editorials and opinions
Documents related to parliament or legislature; national or regional
strategies as they are not the primary source for clinicians
Local guidance
Guidance provided by private providers of diagnostic services
International professional body guidelines (other than ICD/DSM)
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four reviewers (JH, GR, RW and DE) in a comparison of
analysis of three guidelines. The framework was
amended accordingly and is included in Additional file 1.
Data were independently extracted by two reviewers (JH
and HR) from 21 CPGs and disagreements were resolved
by discussion and further checks. Data were tabulated
and analysed.
Analysis of social factors
A modified form of narrative review, as described by
Popay et al. [34] and Ferrari [35], was adopted whereby
data extraction enabled synthesis of key data, whilst also
allowing rich narrative description [35]. Narrative review
was selected as it enabled the telling of the ‘story’ of
CPGs, and consideration of how guidelines, as a set of
texts, shape diagnosis [34].
A process of inductive analysis was undertaken based
on social factors and influences. These were defined, for
the purpose of this review, as contextual factors that in-
fluence diagnosis but are not based on symptoms of aut-
ism. We drew from the concept of a social model of
diagnosis as developed by Jutel and Nettleton [36]. This
model considers how diagnostic classifications and med-
ical diagnoses are socially created and how social forces
– including technological, professional, cultural and
economic forces – contribute to shaping aspects of the
diagnostic process including those related to classification,
the consequences of diagnosis and the process of diagnosis
itself [36]. Overall, a social model challenges the idea of
diagnosis as ‘a moment of clinical purity’ [37] or as a way
simply to identify underlying biological problems. We in-
cluded factors that were relevant to multidisciplinary work-
ing or parental/family influence (the process of diagnosis);
the potential outcomes of diagnosis for the patient and how
HCPs may take this into account (the consequences of
diagnosis); and how issues around classification shape the
diagnostic process such as how borderline cases are dealt
with (diagnosis as a category). This was a dynamic process
whereby data extracts were considered in relation to each
other via conceptual mapping and clustering [34].
Terminology
For the purposes of this review and in line with the Aut-
ism Strategy [38] we use the term ‘autism’ throughout.
Results
Characteristics of guidelines
A total of 236 documents were retrieved, and 21 were
included in the final narrative review (see Table 3 for full
list of included documents and guideline characteristics).
Table 2 Purpose of Diagnostic Guidelines
Type of guideline General purpose of type of guideline
Diagnostic Criteria To assist clinicians in the diagnosis of mental conditions by providing descriptions of the main clinical features in
each category
National Clinical Guidelines To offer best practice advice and guidance for professionals and service users and their families
Guidelines from Professional
Bodies
To offer profession specific advice to clinicians and healthcare professionals in their specialist area
Journal Articles To summarise clinical guidelines in clinician-facing publications to keep clinicians up to date and/or alert them to
changes in good practice
Fig. 1 Full Search Strategy
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The documents studied are grouped into four types: a)
International Diagnostic Criteria (n = 2); b) National
Clinical Guidelines (n = 5); c) Journal articles that
summarize National Clinical Guidelines and the diag-
nostic process, published in key clinical journals (n = 10);
d) Guidelines from professional bodies (n = 4). It should
be noted that journal articles, in some cases, are de-
signed to give an update rather than a full guideline
therefore the lack of detail in some areas should not ne-
cessarily be seen as a weakness.
Of the 21 guidelines considered, six dealt with diagno-
sis of adults, seven with children and eight with all ages.
Of those, two guidelines were international but key to
diagnostic practice in the UK (ICD-10 and DSM-5),
five related to the UK as a whole, five to England and
Wales, one to Scotland, two to Northern Ireland and
one to outside the US and Canada (and therefore in-
cluded the UK). Five guidelines did not specify a geo-
graphical remit but were published in the UK in
clinician-facing journals. All guidelines were aimed at
HCPs, with six aimed at particular specialist roles
that included psychiatrists, psychologists, speech and
language therapists, community practitioners and
paediatricians.
Fig. 2 Study selection flow diagram
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Table 3 Key characteristics of guidelines
Title Year Author(s) Publisher/
Journal
Geographical
remit
Target
audience
Age
range
Range of
diagnoses
covered
Diagnostic
criteria
referred to
Age at which
symptoms are
recognised
DIAGNOSTIC CRITERIA
The ICD-10
Classification
of Mental and
Behavioural
Disorders:
clinical de-
scriptions and
diagnostic
guidelines
[32]
1993 N/A World Health
Organisation
International Clinical,
educational
and service
use
All ages Pervasive
development
disorders
N/A Before age of
3 years
(childhood
autism); after age
3 (atypical
autism).
Diagnostic
and Statistical
Manual of
Mental
Disorders
(Fifth Edition)
[33]
2013 N/A American
Psychiatric
Association
International Clinicians,
students,
practitioners,
researchers
All ages Autism
Spectrum
Disorder
N/A During 2nd year
of life (12–
24 months) or
earlier than
12 months if
developmental
delays are severe
NATIONAL CLINICAL GUIDELINES
NICE Autism
in under 19 s:
recognition,
referral and
diagnosis
(NICE CG128)
[39]
2011 National
Collaborating
Centre for
Women’s and
Children’s
Health
National
Institute for
Health and
Care
Excellence
(NICE)
England and
Wales
Healthcare
professionals
From
birth up
to
19 years
Pervasive
developmental
disorder (PDD)
ICD-10 or
DSM-IV
May be
uncertainty
before
24 months, or
with
developmental
age of less than
18 months
Six Steps of
Autism Care
for children
and young
people in
Northern
Ireland
(RASDN) [44]
2011 Regional
Autistic
Disorder
Network for
Northern
Ireland
Health and
Social Care
Board
Northern
Ireland
Health care
and education
professionals,
parents, carers,
service users
and providers.
Up to
the age
of
18 years
Autism
spectrum
disorder
ICD-10, DSM-
IV, NICE, SIGN,
NZ Guide-
lines, NHS
Map of
Medicine
Pre-school.
Language delay
by the age of
two years.
Autism
Spectrum
Disorder in
adults:
diagnosis and
management
(NICE CG142)
[9]
2012 National
Collaborating
Centre for
Mental Health
National
Institute for
Health and
Care
Excellence
(NICE)
England and
Wales
Health and
social care
providers and
commissioners
Adults
aged 18
and over
Autism
spectrum
disorders
N/S
*ICD-10
specified in
full version of
CG142 [62]
N/A
Autism Adult
Care Pathway
(RASDN) [54]
2013 Regional
Autistic
Spectrum
Disorder
Network
Health and
Social Care
Board
Northern
Ireland
Professionals,
adults and
families
Adults
from age
18
Autism
spectrum
disorders
DSM-5 and
ICD-10, NICE
guidance
CG142.
N/S
Assessment,
diagnosis and
interventions
for autism
spectrum
disorders: A
national
clinical
guideline
(SIGN 145)
[10]
2016 N/A Scottish
Intercollegiate
Guidelines
Network
Scotland Healthcare
professionals
Whole
age
range
Autism
spectrum
disorder
ICD-10 and
DSM-5
Autism can be
reliably
diagnosed
between the
ages of 2–3.
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Table 3 Key characteristics of guidelines (Continued)
Title Year Author(s) Publisher/
Journal
Geographical
remit
Target
audience
Age
range
Range of
diagnoses
covered
Diagnostic
criteria
referred to
Age at which
symptoms are
recognised
GUIDELINES FROM PROFESSIONAL BODIES
RCSLT (Royal
College of
Speech and
Language
Therapists
Clinical
Guidelines
(Autism) [41]a
2005 N/A Royal College
of Speech and
Language
Therapists
UK Speech and
language
therapists
Children
and
adults
Autism
spectrum
disorder
ICIDH-2 (for
general
clinical
assessment)
N/S
Good practice
in the
management
of autism
(including
Asperger
syndrome) in
adults
(RCPych
CR191) [11]
2014 Royal College
of
Psychiatrists
Royal College
of Psychiatrists
UK Psychiatrists
working with
adults of at
least normal
intellectual
ability
Adults
from age
18
Autism ICD-10, DSM-
5, NICE, 2012.
N/S
Autism
Spectrum
Disorders:
Guidance for
Psychologists
(BPS) [40]b
2016 Stuart-
Hamilton,
Dillenburger,
Hood &
Austin
British
Psychological
Society
UK Psychologists All ages Autism
Spectrum
Disorder
ICD-10 and
DSM-5, NICE,
2011.
Both diagnostic
manuals consider
ASD indicators to
be present by the
age of 36 months
although some
children can be
identified under
the age of
24 months.
BMJ Best
Practice
online
resource [43]
2017 Parr
&Woodbury-
Smith
British Medical
Journal
Outside US
and Canada
Medical
Practitioners
All ages Autism
Spectrum
Disorder
DSM-IV, DSM-
5 & ICD-10.
NICE, SIGN,
AACAP, AAP,
NZ ASD
guideline,
AAN
More than 80%
of children with
ASD show clear
behavioural signs
by the age of
24 months, some
indicators in 12–
18 months
JOURNAL ARTICLES
Diagnosis and
management
of autism in
childhood
[47]
2011 Blenner,
Reddy &
Augustyn
British Medical
Journal
N/S General
clinicians
Children Autism
Spectrum
Disorder
DSM-IV TR or
ICD-10
N/S
Diagnosis and
assessment in
autism
spectrum
disorders [48]
2012 Carpenter Advances in
Mental Health
and
Intellectual
disabilities
N/S Those
designing and
providing
diagnostic
services
All ages Autism
Spectrum
Disorder
DSM-IV TR or
ICD-10. Gill-
berg’s for AS.
There are
others but
few use them
(Kopra et al.,
2008; Chiap-
pedi et al.,
2010).
N/S
Autism
spectrum
disorder in
adults: clinical
features and
the role of
the
psychiatrist
[49]
2013 Garland,
O’Rourke &
Robertson
Advances in
Psychiatric
Treatment
UK Psychiatrists Adults Autism
Spectrum
Disorders
ICD-10 and
DSM-5, NICE
To satisfy ICD-10
criteria for child-
hood autism, im-
pairments must
manifest before
the age of
3 years
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Guidelines acknowledged that there is variation in rates
of identification, assessment criteria and practice [9]; that
there is increasing demand for diagnostic services [39]; and
that increased awareness of autism is likely to lead to a rise
in people presenting for assessment [40].
Definitions of autism
Definitions of autism in ICD-10 and DSM-5 differed.
ICD-10 took a categorical approach with a definition of
Pervasive Development Disorders that included
sub-diagnoses within it; whilst DSM-5 used the overarching
Table 3 Key characteristics of guidelines (Continued)
Title Year Author(s) Publisher/
Journal
Geographical
remit
Target
audience
Age
range
Range of
diagnoses
covered
Diagnostic
criteria
referred to
Age at which
symptoms are
recognised
Recognising,
referring and
diagnosing
autism [45]
2012 Howlett &
Richman
Every Child
Journal
England and
Wales
Professionals
working with
children and
young people
Children
and
young
people
Autism NICE The core autism
behaviours are
typically present
in early
childhood; but
features can
appear different
with age or
change with
circumstances
Autism [50] 2013 Lai,
Lombardo &
Baron-Cohen
The Lancet N/S N/S All ages Autism or the
autism
spectrum
DSM-5, ICD-
10
N/S
Autism [51] 2009 Levy, Mandell
& Schultz
The Lancet N/S N/S N/S but
primarily
talks
about
children
Autism
Spectrum
Disorder
DSM-IV and
ICD-10
Parents often
aware from age
18 months, a
diagnosis is often
not made until
2 years after the
initial expression
of parental
concern.
Autism
spectrum
disorder:
diagnosis and
management
[53]
2009 O’Hare Archives of
Disease in
Childhood:
Education and
Practice
Edition
N/S but
relates
primarily to
SIGN
guidelines
Paediatricians Children
and
young
people
Autism
Spectrum
Disorder
ICD-10 and
DSM-IV, SIGN
N/S
Recognition,
referral,
diagnosis,
and
management
of adults with
autism:
summary of
NICE
guidance [58]
2012 Pilling, Baron-
Cohen,
Megnin-
Viggars, Lee &
Taylor
British Medical
Journal
England and
Wales
N/S Adults Autism N/S N/S
Autism
Spectrum
Disorders in
childhood: a
clinical
update [46]
2011 Reynolds Community
Practitioner
UK Community
practitioners
Children Autism
Spectrum
Disorder
ICD-10, DSM-
IV
N/S
The NICE
guideline on
recognition,
referral,
diagnosis and
management
of adults on
the autism
spectrum [52]
2014 Wilson,
Roberts,
Gillan, Ohlsen,
Robertson &
Zinkstok
Advances in
Mental Health
and
Intellectual
Disabilities
England and
Wales
Health care
professionals,
service
managers,
service users,
practitioners
All adults Autism
spectrum
disorder
N/S N/S
aPre 2009 but constitutes current guideline in use from RCSLT
bCurrently under review but represents the most recent published guideline from BPS
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dimensional concept of Autism Spectrum Disorder. Some
inconsistencies were present related to the differences in
classification in ICD-10 and DSM-5, therefore, for example,
Rett’s Syndrome and Asperger’s Syndrome were
sub-diagnoses of Pervasive Development Disorders in
ICD-10, but were encompassed in the overarching diagno-
sis of Autism Spectrum Disorder in DSM-5 [32, 33]. Defini-
tions of autism in all other guidelines considered in this
study were broadly consistent with the idea of a ‘spectrum’.
Most guidelines (n = 14) referred to symptom criteria
from both ICD-10 and the (then) current version of
DSM (DSM-IV up to 2012 and DSM-5 from 2013), with
eight guidelines recommending that HCPs should use
the current version of DSM or ICD criteria for diagnosis.
Exceptions were NICE CG142, which was based on
ICD-10, [9]; Royal College of Speech and Language
Therapists (RCSLT) [41], which drew on the Inter-
national Classification of Functioning, Disability and
Health (ICIDH-2) for general clinical assessment [42];
and journal articles describing NICE guidelines which
made no mention of DSM/ICD (n = 3).
Overall, therefore, the guidelines were mixed in their
recommended sources for symptom criteria due to the
current differences in the two classification systems.
Narrative review of social factors
We used three inter-related elements as an organising
framework to describe the social factors identified in
clinical guidelines: operational, interactional and con-
textual. These factors do not stand alone from each
other, indeed, they appear to have a dynamic and
inter-dependent relationship, however, organising them
provides a way to map their range and scope (see Fig. 3).
Operational factors
Operational factors included how different assessment
processes impact on the diagnostic decision, such as
which tools and processes are engaged and when; what
constitutes an assessment; and whether the decisions
take place as part of diagnosis or formulation. Table 4
outlines some of these operational factors.
The assessment process
One guideline suggested that clinical practice varies
greatly [43] and we found this to be mirrored in CPGs
with a wide range of potential assessment processes in-
cluded. DSM-5 recommended that a diagnostic assess-
ment should include gathering multiple sources of
information from clinician’s observations, caregiver
Fig. 3 Social factors in clinical guidelines
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history and self-report (where possible). National guide-
lines, although providing far greater detail, tended to
include these areas and additionally suggested various other
detailed assessments such as gathering wider functional/as-
sessment information [10]; using documentary evidence,
assessing risks, and assessment of challenging behaviour
[9]; assessing for co-conditions [9, 39]; physical examination
[39]; comprehensive educational assessment [44]; assess-
ment of communication, neuropsychological functioning,
motor and sensory skills, and adaptive functioning [10].
Professional guidelines added other factors such as compre-
hensive cognitive assessment [40] and impact of individual’s
mental health [41], accounts of relationships in different
settings [11] and observation in school or another setting
[43]. Journal articles tended to reflect national guidelines
and varied in the level of detail outlined for assessment fac-
tors. Two articles gave little detail of assessment processes
but one referred readers directly to NICE guidelines for fur-
ther detail [45] and the other was aimed at community
practitioners who would be more likely to be involved in re-
ferral than diagnosis [46]. Articles also included assessment
of co-occuring conditions (e.g. [47–52]) and a physical or
medical examination (e.g. [47, 50]). Additional assessment
areas included assessment of specific domains such as fam-
ily stressors and coping abilities [47]. In one guideline [48]
it was suggested that some clinicians bypass ICD/DSM cri-
teria and instead undertake:
‘…testing for specific underlying difficulties such as
lack of theory of mind or lack of central coherence
and then using these to decide the presence of the
behavioural criteria’ [48].
The RCSLT guideline [41] differed from most by sug-
gesting consideration of theories relating to the triad of
social impairments, such as executive functioning defi-
cits, motivation, memory and central coherence, as well
as social interaction and communication. However, some
(e.g. [40]) suggested cognitive or neuropsychological
testing whilst SIGN guidelines stated that such assess-
ments are ‘useful for individual profiling but are not
diagnostic instruments’ [10]. This anomaly may reflect
the specialist role of SLTs in the diagnostic process.
Overall, we would concur with a reflection in one
guideline, which noted how the HCP may be faced with
‘possible uncertainty as to where to go next in their in-
vestigation framework as this could be potentially enor-
mous’ [53].
Diagnostic tools
Recommendations about the use of diagnostic tools were
mixed. One third of the guidelines (n = 7) did not specify
any particular tool for diagnostic assessment. Other
CPGs tended to suggest the consideration of a range of
tools without specifically recommending any particular
instrument(s), although regular references were made to
ADOS (n = 13), ADI-R (n = 11), DISCO (n = 9) and 3di
(n = 6). The NICE guideline for children and young
people emphasised use of DSM/ICD criteria rather than
tools; the NICE guideline for adults did the opposite [9,
39]. Overall, findings concurred with Penner et al. in
that guidelines varied substantially in their recommenda-
tions for use of diagnostic tools [29].
Diagnosis and formulation
There were differences in the way guidelines described
the relationship between, or referred to, diagnosis,
assessment, profiling, needs assessment and wider
formulation. All guidelines encompassed the concept of
a wider (needs related) assessment but few explicitly sep-
arated out these processes or discussed how this related
to a diagnostic assessment. One exception to this was
the Regional Autistic Spectrum Disorder Network
(RASDN) children’s guideline, which separated the diag-
nostic from the formulation process, describing the
latter as including examination of the person’s wider
environment:
‘The outcome of the formulation should be to
understand an individual in a more global holistic way
rather than merely in terms of signs and symptoms,
as in the case of diagnosis’ [44].
The RCPsych guideline suggested that diagnosis is
only one component of the wider multidisciplinary exer-
cise [11]. Some guidelines did not mention formulation
but suggested a profile of strengths, abilities and weak-
nesses should be carried out alongside a diagnostic
assessment (e.g. [10, 39]). Adult guidelines from RASDN
separated out a diagnostic assessment from a full needs
assessment [54]; NICE guidelines for adults considered
comprehensive assessment to include diagnostic,
needs and risk assessment [9]; whilst the full chil-
dren’s guidelines similarly brought together the diag-
nostic and needs elements under ‘autism diagnostic
assessment’, explaining that:
‘..the label of autism does not constitute a complete
diagnostic assessment and a profile of the child or
young person’s strengths and weaknesses is also
essential. This requires a multidisciplinary team which
has the skills to undertake the assessments necessary
for profiling’ [55].
Operationally, therefore, there were contradictions
between guidelines about what constitutes the diagnostic
process, how it should be structured and which diagnos-
tic tools should be used.
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Interactional factors
Interactional factors related to how the dialogue between
HCPs and between HCPs and families impacts on the
assessment process. These include how consensus is
reached, how disagreement is resolved and how the
views of the person and family are integrated into the
decision-making process.
Multidisciplinary assessment versus single practitioner
assessment
Where specified, all guidelines advocated for diagnosis
to take place within a multidisciplinary setting with vari-
ous guidelines suggesting this was ‘necessary’ [44], the
‘optimum approach’ [10] or ‘ideal’ [43] (See Table 4).
Some suggested (n = 4) that an appropriately trained and
experienced single professional is sufficient to diagnose
in particular cases, but to be alert for indications for a
more specialist assessment [11] and with access to
multidisciplinary support if required [48].
Despite this almost universal recommendation, the ex-
tended version of NICE children’s guidelines (and cited
by SIGN [10] and Carpenter [48]) questioned the evi-
dence base for multidisciplinary assessment reporting a
study [56] that showed moderate agreement between an
individual HCP and an MDT in making a diagnosis, but
stating that it was a low quality study [55]. These guide-
lines also suggested in practice that a diagnosis can be
made by a single experienced HCP but that a compre-
hensive profile of the patient requires a multidisciplinary
approach [55]. SIGN guidelines also cited research [57]
which demonstrates that parents value a multidisciplin-
ary assessment [10].
None of the guidelines in this review dealt with how
HCPs come to a consensus within a multi-disciplinary
context, although Northern Ireland guidelines recom-
mended that training should include the promotion of
collaborative and innovative working [44] and that clini-
cians must understand the profession specific roles and
responsibilities of the overall team [44, 54].
Therefore, most guidelines referred to MDTs as best
practice, but lacked recommendations about how roles
within MDTs are negotiated, how disagreement is re-
solved (other than second opinion outside the team); or
how teams should work together, a factor that is ac-
knowledged by NICE adults guideline [9].
Interaction with the person and their family
Many guidelines (n = 9) outlined the importance of keep-
ing the person/family informed and involved throughout
the process or recommended a person-centred approach.
Some described the relationship with the person coming
for diagnosis and their family as a partnership (e.g. NICE
adult guideline [9]) or as person-centred (e.g. RASDN adult
guideline [54]). Some guidelines (n = 6) acknowledged that
the person or family may disagree with or be reluctant to
accept a diagnosis or, alternatively desire one [46] and be
determined on a particular outcome, which can lead to
misleading results [11]. Carpenter asserted that some
people may begin to see diagnosis as a desirable outcome
and pre-prepare answers based on structured interviews
published on the internet [48]. The potential for disagree-
ment or desire for diagnosis, therefore, may impact on the
interaction with the person or their family. So, although the
relationship with the patient/family is considered within
CPGs, there is little guidance as to how HCPs might deal
with patient/family desire or disagreement.
Contextual factors
There were factors related to the way in which HCPs inter-
pret symptoms in different settings, how diagnostic thresh-
olds are judged against criteria and included considerations
around the impact and consequences of a diagnosis.
Interpreting needs
All national guidelines (n = 5) outlined the requirement to
consider the needs, preferences and values of the individ-
ual and their family and/or support them to communicate
their needs and concerns. Most guidelines (n = 17) de-
scribed elements of diagnosis that relate to either family
environment, family needs and concerns, circumstances,
relationships, functioning, experiences in different set-
tings, contextual information or level of support needs.
Many guidelines reflected the need to consider assessment
of support required. Enquiries should be made about how
symptoms impact on function within the family, at home,
school or work [9, 39, 47, 54, 58]. Overall, therefore, there
was a focus not only on the assessment of symptoms, and
the way in which these affect the daily life of the person
and their family, but the wider environmental and social
context of the person and the way in which they are sup-
ported, or not, by that context.
Masking and social context
Some guidelines (n = 6) reported the difficulties of diag-
nosing autism when compensation strategies may ‘mask’
difficulties in some contexts, particularly as an adult
[33], and in girls [50] where autism may go unrecog-
nised. Some suggested that individuals may come for-
ward for diagnosis when their circumstances change
and/or stressors increase (e.g. [10, 45, 54]). Some guide-
lines (n = 5) noted that cultural differences will exist in
norms for social interaction or that cultural variations
can deliver misleading signs and symptoms. DSM-5 sug-
gested that the boundaries between normality and path-
ology differ between cultures and the level at which
experience may become problematic may differ [33].
SIGN suggested that those with autism may not have
met ‘normal’ adult milestones in work, relationships or
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independence and contained extensive information on
how females can present with a different symptom profile
[10]. Others warned that behaviours might be the result of
disruptive home experiences, carer illness [39] or complex
psychosocial or child protection backgrounds [53].
Despite research showing links between diagnostic
rates and SES, there was very little mention of the im-
pact of SES in CPGs. DSM-5 stated that cultural and so-
cioeconomic factors may affect age at recognition or
diagnosis [33] but generally guidelines failed to consider
how this might be considered in practice, other than to
be aware that ‘cultural variations can deliver misleading
signs and symptoms’ [45] or that autism is ‘not restricted
to particular ethnic or economic backgrounds’ [40].
RCSLT guidelines considered assessment of bilingual in-
dividuals [41] and some suggested that ethnicity may
delay engagement in the diagnostic process [11] or may
increase difficulty in accessing services [54].
Overall, guidelines suggested it was the responsibility
of the HCP to make a judgement about which behav-
iours appear to be ‘normal’ in complex social and family
circumstances, as well as against norms for behaviour.
Diagnostic uncertainty, thresholds and the role of clinical
judgement
Overall the general focus of guidelines was to outline a
framework to find the best way to decide whether autism
is present or not around a threshold of symptom severity.
However, many guidelines problematized this, for ex-
ample, one guideline discussed how definitions of autism
have changed with DMS-5 [11] and others suggested that
social factors, such as an upbringing characterized by lack
of boundaries [45] or symptoms amplified by distress [11]
may cause diagnostic difficulties.
All national guidelines considered uncertainties
around diagnosis, particularly with very young chil-
dren or those with co-existing disorders [39]; when
there may be disagreement within the diagnosing team or
between the team and the patient or family, or when there
is a lack of local expertise [9]. Many warned of diagnostic
difficulties, or ‘obscuring’ [11, 53] that can take place if
there is an intellectual disability or other complex coexist-
ing condition and several considered the difficulties of
overlapping diagnostic criteria [33, 50, 51, 53]. Further un-
certainty was outlined when individuals may not reach the
diagnostic threshold [39] or when children with autism
score below the cut-off as determined by the diagnostic
instrument [43].
Despite this uncertainty, CPGs generally proposed a
systematic approach to diagnosis and, in some cases,
asserted that progress has been achieved in establish-
ing consensus around a behavioural definition and
established systematic clinical assessments (e.g. [50])
even whilst recognizing that the ‘boundaries between
disorders are more porous than originally perceived’ [33].
Eight guidelines stressed the key role of clinical
judgement in the diagnostic process. DSM-5 outlined
that the use of diagnostic criteria should be informed
by clinical judgement [33] and ICD-10 suggested that
guidelines should be used flexibly in clinical work
[32]. The full version of NICE children’s guideline
recommended: ‘Use information from all sources, to-
gether with clinical judgement, to diagnose autism
based on ICD-10 or DSM-IV criteria’ [55]. One guide-
line suggested that clinicians may depend on the ‘feel’
of the interaction with the patient for diagnosis [48].
The RCPsych guideline stated that:’…much will de-
pend on the extent of the clinician’s experience, their
rigour in applying standard criteria and their ability
to recognise alternative diagnoses’ [11]. Uncertainty,
clinical judgement and clinician experience, therefore,
were all identified as important factors in the diag-
nostic process.
Pragmatic outcomes and diagnostic value
Most guidelines (n = 17) discussed the need for HCPs
to have knowledge of local support and resources
available to deliver appropriate advice when required.
The value of the diagnosis was generally described as
a way to provide appropriate support, intervention
and resources. NICE guidelines for children and
young people clarified this:
‘Diagnosis and the assessment of needs …can open
doors to support and services…all of these can
improve the lives of the child or young person and
their family’ [39].
However, NICE guidelines for adults acknowledged
that adults who are diagnosed may receive no support
due to lack of services [9] and Pilling et al. stated that
whilst care for children and young people is generally
well coordinated, this is not always the case for adult
services [58].
Although some guidelines acknowledged that people
may not want a diagnosis and the label it brings with it
(e.g. [44, 54]) or that it can be stigmatising or damaging
to career plans [11], generally guidelines described the
benefits of a diagnosis primarily as relating to improved
quality of life, creating an opportunity to have needs
met, greater understanding and reassurance about one’s
own situation and access to interventions and services.
Some guidelines considered that diagnosis can provide
relief, understanding or an opportunity to move on with
increased support [11, 39, 45].
Many guidelines stressed the importance of early diag-
nosis as this enables early intervention which leads to
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improved health outcomes (e.g. [41, 44, 47, 50]). How-
ever, the BMJ guideline asserted that the, ‘…efficacy of
early intervention varies from child to child’ [43], and
that ‘consideration of the direct financial costs, indirect
costs… and the impact on relationships within the fam-
ily… must be balanced against likely and possible im-
provements in outcome for the person with ASD’ [43],
bringing uncertainty into the benefits of diagnosis. Fur-
thermore, O’Hare asserted that it is difficult to prove
that earlier intervention is more effective [53].
Overall, guidelines reflected a concern about the
potential impact or benefits on the child or adult receiv-
ing a diagnosis and considered positive factors such as
access to support and intervention, increased under-
standing or relief; as well as potential negative impacts
such as stigma. Carpenter, however, questioned the rela-
tionship between need and diagnosis, by asking whether
diagnosis is influenced by what intervention the person
needs or ‘…explicitly determined by the person’s need to
have the label to access a service… rather than their
fitting strict diagnostic criteria?’ [48].
To conclude, whilst CPGs appeared to frame a meth-
odical and clinical diagnostic process, they also
rehearsed a number of subjective dilemmas that HCPs
have to negotiate along the way. Some CPGs themselves
drew attention to social issues that muddle the process:
the difficulties of establishing a clear threshold in a con-
dition where symptoms are impacted by the stressors of
environment [11]; the problem of relying on mechanistic
assessments or algorithms [11, 48]; the crucial role of
clinical judgement [54]; the possibility of diagnostic un-
certainty through disagreement, lack of local expertise or
when a complex coexisting condition is present [9]; the
complexity caused by interaction with co-occurring con-
ditions; masking of autism by comorbid conditions in
secondary care [58]; the impact of good (or poor) social
support and coping strategies on how symptoms present
[33], to name a few.
Discussion
We found that CPGs varied in how they described the
diagnostic process in relation to use of diagnostic tools,
key elements and structure of the diagnostic process (for
example how diagnosis related to wider needs assess-
ment) and how autism was classified, defined either by
current versions of DSM or ICD. In addition, whilst
some recommendations were clear and universal, for
example, recommendations for multidisciplinary work-
ing, there was little guidance as to how this should work
in practice.
In addition, we found that uncertainty was central to
many diagnostic decisions, placing a great emphasis on
clinical judgement. This uncertainty included questions
around the benefits of early intervention, the shifting
nature of the diagnostic threshold, the difficulties of
interpreting needs in different social contexts, the prob-
lems of interpreting ‘masking’ or coping strategies, the
differences in presentation across age and breadth of
symptoms, the inter-relationship with co-conditions and
sharing of symptoms, the impact of stressors on symp-
toms as well as interpretation of symptoms and needs in
different cultural contexts.
Overall, therefore, our narrative review found that al-
though individual guidelines appeared to present a co-
herent and systematic assessment process, they varied
enough in their recommendations to make the choices
available to healthcare professionals particularly complex
and confusing; and presented a context of uncertainty
which appeared to be central to the diagnosis of autism.
We argue that clinical guidelines for autism diagnosis
illuminate the process of diagnosis as social rather than
straightforwardly clinical, and that judgement is required
to consider a number of sometimes contradictory and
complex social factors.
Social factors in CPGs
Organising the narrative review findings in relation to
operational, interactional and contextual factors enabled
consideration of the influence of social factors through-
out the diagnostic process.
In the wide range of inter-related assessment processes
that HCPs negotiate in order to make the diagnostic
decision, the factors considered appear to be both social
and medical. Social factors include: how the category of
‘autism’ is defined and boundaried; operational and
interactional factors present in the process of diagnosis;
to the consequences of diagnosis including how diagno-
sis is valued (see Fig. 3). Each of these factors had a
place in clinical guidelines to a greater or lesser extent
but in many cases they were not operationalized to
enable a clear and transparent framework. For example,
although there were many references to individuals
masking symptoms, family ‘scaffolding’ of social impair-
ment and coping strategies, there was little guidance
about how HCPs can judge the impact of these on need,
behavioural symptoms or functioning.
CPGs, therefore, tended to mask (whilst paradoxically
acknowledging) the existence of social factors in the
diagnostic process. A more explicit acknowledgement of
social factors and how to manage them might
problematize the nature of autism diagnosis altogether:
if all these factors have a place in diagnosis, how do they
relate to clinical factors and what does it mean for
descriptions of symptoms? Whilst it is not our intention
to undermine the utility of diagnostic categories in rela-
tion to access to resources or support, there appears to
be a need for balance in CPGs between a clinical
approach which both recognises and acknowledges the
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uncertainty of the diagnostic threshold; and a pragmatic
or functional approach which responds to individual and
wider needs and takes account of social factors.
Diagnostic tools and process
Clinical guidelines for autism varied in aspects of their
key recommendations in operational factors. Ambigu-
ities around which tools to use, the key elements in the
diagnostic process and the relationship between diagno-
sis, assessment and formulation suggest that local prac-
tice may be shaped by other factors, such as available
resources, experience and professional roles. Which
tools are used, whether different elements of the process
are considered together, sequentially or inconsistently,
and the specific aims of each part of the assessment
process may have an impact on diagnostic outcomes. A
clearer framework would help HCPs to consider which
elements of the process are relevant and when.
MDT working and views of the family
Guidance about how HCPs can reach a consensus with
others in a multidisciplinary context or deal with
patient/family disagreement or desire was lacking, leav-
ing interactional factors as key to the process but largely
unexplained. Whilst it might not appear to be in the
remit of CPGs to make specific recommendations about
how teams are organised and configured, particularly
across different health systems, we argue that team func-
tioning as a key shaping factor in diagnosis requires
more attention in CPGs, to ensure clarity of roles and
transparency for those coming for diagnosis. Similarly,
as acknowledged by some CPGs, desire of the patient/
family can influence the diagnostic process, therefore
CPGs should offer guidance about how that might be
managed.
Diagnostic uncertainty and judgement
Uncertainty about diagnostic thresholds and differences
in diagnostic criteria make clinical judgement key to the
diagnostic process and yet how this comes about was
not clearly defined. The extent to which diagnosis
should be based on underlying symptoms versus con-
textual factors such as wider needs or circumstances of
the individual was unclear. In addition, how HCPs con-
sider the consequences of the diagnosis for the patient
and their family was unclear, although there was a strong
link described between diagnosis and access to support.
Ambiguities in CPGs suggest that guidelines have limi-
tations in how far they are able to promote consistency
across practice especially given the lack of a biomarker
for autism, the reliance on observed behaviour and fam-
ily narratives for diagnosis, and the differences across
health systems. However, adults, children and families
coming for diagnosis might expect a consistent process
of assessment in keeping with a framework outlined in
CPGs, as CPGs become a fixed reference point both for
HCPs and the lay public. There is, therefore, a tension
between potential expectations of those coming for diag-
nosis that there should be a uniform process; and the
flexibility HCPs require to respond to individual need.
Given the social nature of diagnosis as argued in this
article, biomarker use in clinical practice, if and when it
is successfully developed, is likely to remain only one as-
pect of an interactive diagnostic process, and therefore
may not necessarily alleviate some of the difficulties and
complexities of diagnosis that we describe. However, as
biomarker research develops, it is likely that it will pro-
duce important evidence to be considered in the devel-
opment of future CPGs.
Building on previous work
Whilst our narrative review differed in purpose to the
systematic review undertaken by Penner et al. [29], there
were some similar findings across the two studies. We
found, as did the authors of this previous review, that
guidelines were inconsistent in their recommendations
around diagnostic assessment. For example, whilst
guidelines generally recommended MDT assessment,
some suggested that a single experienced clinician could
diagnose [11, 39, 48] and there was little cited evidence
for the efficacy of MDT assessment. In addition, CPGs
did not provide guidance as to how waiting times (where
specified) would be achieved and we would add that they
provided little operational guidance as to how MDT
decision-making should operate to be most effective. We
found, as did Penner et al., that guidelines varied sub-
stantially in recommended tools and personnel; and that
none of the professional guidelines provided target
waiting times for assessment (See Table 4). Whilst we
did not assess guidelines for quality, we agree that there
are multiple guidelines that HCPs might access, and that
they vary in their level of detail and their
recommendations.
We built on Penner et al.’s findings in a number of
ways. Our review of the range of assessment processes
that HCPs involved in autism diagnosis may undertake
(See Table 4) suggested a wide range of choices in as-
sessment processes. We also found that using different
classification criteria (ICD-10 and DSM-5) further in-
creases complexity in CPGs. Finally, we found that con-
sideration of factors such as interaction with the patient
and family, how needs might be defined and assessed,
and issues of masking, social context, uncertainty and
clinical judgement highlighted the way in which social
processes and factors might impact on diagnostic
decision-making. We also found that, despite the CPGs
in our study operating within comparable health systems
across the UK, CPGs did not make consistent
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recommendations around how diagnosis might release
post-diagnostic resources, and what that means for the
process of diagnosis itself.
Overall we agree with Penner et al.’s findings that
CPGs should incorporate flexibility to ensure that indi-
vidual needs are met. Additionally, we suggest that
guidelines should acknowledge more explicitly the social
framing of diagnosis and support clinicians with a
framework which enables them to act pragmatically
in the best interests of the patient. We would argue
that inconsistencies and lack of operational guidance
around social factors in CPGs suggests that local fac-
tors such as access to resources and HCP expertise
are likely to shape diagnosis more than is explicitly
outlined in CPGs.
Unlike Penner et al., we do not think that a formal ap-
proach to decision-making such as the Delphi method
would help HCPs in the assessment process; rather it
might simply add another layer of complexity to a
process which is already challenging. Our experience is
that HCPs already struggle to find time to meet together
in the context of an ever-increasing workload; an extra
administrative burden may make this even more
difficult.
Finally, unlike Penner et al., we included in our review
CPGs for adult diagnosis and children over 6 years old,
which enabled us to consider factors common across
age groups. Whilst we did not specifically look for differ-
ences between children’s and adult’s CPGs we are aware
that the different pathways for children’s and adult’s
assessment [3, 59], may well impact on an individual’s
ability to access diagnostic services, the process of assess-
ment itself as well as potential support post-diagnosis. We
would consider these differences as social organisational
factors that may impact the assessment process and merit
further consideration in the development of future CPGs.
Guidelines, therefore, appear to offer a relatively linear
and straightforward pathway towards a diagnostic deci-
sion in their presentation, with DSM-5 asserting that
criteria facilitate an objective assessment of symptom
presentations in a variety of settings [20]. However,
comparing individual guidelines suggests inconsistencies
in this framework and close analysis reveals a more fluid
process, disrupting the apparent clinical purity of
diagnosis [37].
Conclusion
Overall, there was a bewildering range of options for
HCPs in the assessment process, and a number of differ-
ent emphases in guidelines which might lead a clinical
team one way or another. Navigating this framework in
practice is, therefore, likely to be less systematic than the
guidelines might suggest, allowing for, as it must, social
and contextual influences. In reality, the clinical pathway
for autism diagnosis differs across health systems and
trusts across the UK [3] leading to the potential for a
great deal of variation in diagnostic decision-making.
Strengths and limitations
Although there has been a recent systematic review of
clinical guidelines [29], we consider our narrative
approach to be helpful to understand the complex and
sometimes contradictory nature of the diagnostic
process. Methodologically, we undertook a systematic
search and included a transparent but pragmatic selec-
tion of documents. This is, to our knowledge, the first
review which strives to consider where social factors are
considered in clinical guidelines for autism diagnosis.
One limit was that as it was a review of current guide-
lines, changes through time were not exposed. Our
review was limited to the UK context because health
care settings vary widely in international contexts. In
addition, we only examined the content of guidelines
rather than how they are used. Whilst CPGs are
intended to assist clinical decision-making by improving
effectiveness and decreasing variations in clinical prac-
tice [60], one review of guidelines for psychiatric diagno-
ses suggested that CPGs are not implemented enough in
clinical practice due to either lack of agreement or ambi-
guity between guidelines [61]. It is likely that there is
wide variation in how CPGs are used in practice in aut-
ism diagnosis and we plan further studies to consider
this.
Implications and recommendations for future research
Social factors were not only explicit in guidelines, but
were central to them. However, an observer might be
forgiven for assuming these are subsidiary factors in
diagnosis, with the more ‘medical’ ‘symptom checklist’ at
its core. HCPs are expected, as outlined in DSM-5, to in-
tegrate the social, psychological and biological in case
formulation, however, greater clarity about how this
should operate would be helpful. Our findings suggest
that more detail about how clinical judgement should
consider social factors in diagnosis would provide a
more transparent guideline for HCPs.
We would not recommend greater rigidity within
CPGs when evidence for best diagnostic practice is in-
consistent (e.g. use of diagnostic tools), and which may
restrict HCPs in making decisions that are in the best
interest of the person coming for diagnosis. Rather we
recommend a more explicit acknowledgement of social
factors in CPGs with advice about how they should be
managed and operationalised to enable more consistency
of practice and transparency for those coming for
diagnosis.
Specifically, greater clarification is required related to
the sequence and timing of the diagnostic, assessment
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and formulation processes. The recognition and assess-
ment of needs is both part of the assessment process
and inextricably linked to the consequences of diagnosis;
guidelines might attempt to consider how these might
be reconciled. A greater acknowledgement of the active
role of the patient, client or patient’s family in the diag-
nostic process would help to place potentially competing
narratives into context. It would be useful to consider
whether guidelines are culturally specific to health ser-
vices and setting and we would recommend that further
narrative reviews should be conducted to examine CPGs
in other countries. In addition, greater clarity is required
around how multidisciplinary interaction might operate
to support consensus decision-making. Further research
creating an evidence base on best practice for multidis-
ciplinary decision-making and the use of different diag-
nostic tools in practice is required, taking into account
the complexity of social factors in diagnosis.
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